With the FDA banning last week the Rimonabant Obesity Drug, all eyes (and mouths) are now focused on the new drug Alli, that coincidentally was launched last week. The main component of Alli, is Orlistat, a drug approved by the. …

article continues at Jurassic brought to you by diet.medtrials.info and conSALSITA